文献速递脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血的院际转诊趋势:2006至2017年单中心经验

Trends in Hospital-to-Hospital Transfers for Aneurysmal Subarachnoid Hemorrhage: A Single-Institution Experience from 2006 to 2017.
PubMed 文献 · World Neurosurg · 2020-12-24

本研究分析2006至2017年间转诊至高容量中心的动脉瘤性蛛网膜下腔出血患者,发现转诊数量从213例降至160例,但转诊患者合并症更多、改良Fisher评分4级比例增加;尽管如此,平均住院时长、院内死亡率及通胀调整后住院费用均下降。

要点

  • 转诊量下降但患者复杂度增加,改良Fisher 4级比例上升
  • 住院时长、院内死亡率和通胀调整后费用均下降
  • 自费或Medicaid比例未变,提示转诊模式变化影响结局数据与质量报告

核心结论

  • 2006至2017年间转诊至本中心的aSAH患者数量下降,但转诊患者病情更复杂、合并症更多、血管痉挛风险更高。
  • 尽管患者复杂度增加,平均住院时长、院内死亡率和通胀调整后住院费用均下降。

研究设计与样本

  • 单中心回顾性分析,纳入2006至2017年转诊至该高容量中心的aSAH患者。
  • 按三个时间段(2006-2009、2010-2013、2014-2017)比较,并按治疗方式(血管内 vs 显微外科)进行亚组分析。

主要发现

  • aSAH转诊数量从2006-2009年的213例下降至2014-2017年的160例。
  • 就诊时Hunt和Hess评分无变化,但改良Fisher评分4级的百分比从2006-2009年至2014-2017年增加。
  • 转诊患者合并症指数更高,预测10年生存率更低。
  • 平均住院时长下降,院内死亡率从2006-2009年至2014-2017年下降,尤其在血管内治疗队列中。
  • 通胀调整后住院费用从2006-2009年的76,975美元下降至2014-2017年的59,870美元。

关键数值与推荐

  • 转诊数量:2006-2009年213例,2014-2017年160例。
  • 通胀调整后住院费用:2006-2009年76,975美元,2014-2017年59,870美元。
  • 自费或Medicaid患者比例无变化。

临床怎么用

  • 高容量中心应预期转诊aSAH患者合并症更多、Fisher评分更高,需优化血管痉挛监测与重症管理。
  • 转诊模式变化对结局数据、质量报告、住院医师培训及 care 系统开发有影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite evidence to support that aneurysmal subarachnoid hemorrhage (aSAH) is best treated at high-volume centers, it is unknown whether clinical practice reflects these findings. METHODS: We analyzed patients transferred to our high-volume center for aSAH between 2006 and 2017. Data collection included number of transfers, demographic data, Hunt and Hess score, Fisher score, comorbid conditions, length of stay (LOS), discharge disposition, in-hospital mortality rates, insurance status, and hospital charges. Comparisons were made across 3 time periods (2006-2009, 2010-2013, and 2014-2017) and included subgroup analyses by treatment modality (endovascular vs. microsurgical). RESULTS: aSAH transfers declined from 213 in 2006-2009 to 160 in 2014-2017. While there was no change in presenting Hunt and Hess scores, the percentage of modified Fisher scores of 4 increased from 2006-2009 to 2014-2017. Transferred patients had a greater comorbidity index and decreased predicted 10-year survival. Despite this, the average LOS decreased. In-hospital mortality decreased from 2006-2009 to 2014-2017, especially in the endovascular cohort. The proportions of patients who were either self-pay or Medicaid did not change. Overall inflation-adjusted hospital charges decreased from $76,975 in 2006-2009 to $59,870 in 2014-2017. CONCLUSIONS: Between 2006 and 2017, transfers to our center for aSAH declined. However, transferred patients had greater levels of complexity, more comorbidities, and were at greater risk for vasospasm based on their presenting Fisher score. Nonetheless, average LOS, in-hospital mortality, and cost declined. These changing referral patterns have implications for outcome data, quality reporting, resident education, and developing systems of care to optimize outcomes.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Adamczak S, Fritz R, Patel D, et al. Trends in Hospital-to-Hospital Transfers for Aneurysmal Subarachnoid Hemorrhage: A Single-Institution Experience from 2006 to 2017. World Neurosurg. 2020. PMID: 33359879. doi:10.1016/j.wneu.2020.11.111

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。